EA200201122A1 - Способ получения производного тетразола - Google Patents

Способ получения производного тетразола

Info

Publication number
EA200201122A1
EA200201122A1 EA200201122A EA200201122A EA200201122A1 EA 200201122 A1 EA200201122 A1 EA 200201122A1 EA 200201122 A EA200201122 A EA 200201122A EA 200201122 A EA200201122 A EA 200201122A EA 200201122 A1 EA200201122 A1 EA 200201122A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
tetrazol
potassium
imidazol
biphenyl
Prior art date
Application number
EA200201122A
Other languages
English (en)
Other versions
EA004633B1 (ru
Inventor
Янош Фишер
Илдико Балло
Эндрене Петеньи
Янош Крейдл
Ласло Цибула
Андраш Немеш
Ида Дойчне Юхас
Эва Веркне Папп
Юдит Надьне Багди
Иштван Хегедюш
Йенёме Фаркаш
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of EA200201122A1 publication Critical patent/EA200201122A1/ru
Publication of EA004633B1 publication Critical patent/EA004633B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Изобретение относится к способу синтеза лозартана калия формулы (I), имеющего химическое название 2-н-бутил-4-хлор-1-[(2'-(тетразол-5-ил)-1,1'-бифенил-4-ил)метил]имидазол-5-метанол калия, с использованием в качестве исходного соединения 2-н-бутил-4-хлор-1-[(2'-(2-трифенилметил-2Н-тетразол-5-ил)-1,1'-бифенил-4-ил)метил]-1Н-имидазол-5-метанол формулы (III). Согласно заявленному способу, соединение формулы (III) реагирует со спиртом формулы (VI), где R представляет собой C-Cлинейную алкильную группу, в присутствии 0,1-1 эквивалента гидроксида калия. Конечный продукт формулы (I) выделяют после кристаллизации при замене используемого растворителя на апротонный или слабопротонный растворитель.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200201122A 2000-04-21 2001-04-20 Способ получения производного тетразола EA004633B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001618A HU222773B1 (hu) 2000-04-21 2000-04-21 Eljárás egy ismert tetrazolszármazék előállítására
PCT/HU2001/000047 WO2001081336A1 (en) 2000-04-21 2001-04-20 Process for the synthesis of a known tetrazol derivative

Publications (2)

Publication Number Publication Date
EA200201122A1 true EA200201122A1 (ru) 2003-04-24
EA004633B1 EA004633B1 (ru) 2004-06-24

Family

ID=89978280

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200201122A EA004633B1 (ru) 2000-04-21 2001-04-20 Способ получения производного тетразола

Country Status (17)

Country Link
US (1) US6710183B2 (ru)
EP (1) EP1274702B1 (ru)
JP (1) JP2003531203A (ru)
AT (1) ATE259366T1 (ru)
AU (1) AU2001254998A1 (ru)
BG (1) BG65699B1 (ru)
CZ (1) CZ301029B6 (ru)
DE (1) DE60102008T2 (ru)
EA (1) EA004633B1 (ru)
EE (1) EE05064B1 (ru)
ES (1) ES2215130T3 (ru)
HU (1) HU222773B1 (ru)
PL (1) PL198664B1 (ru)
SK (1) SK286740B6 (ru)
TR (1) TR200401058T4 (ru)
UA (1) UA72803C2 (ru)
WO (1) WO2001081336A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520446A (ja) * 2001-05-18 2004-07-08 オーロビンド ファーマ リミテッド ロサルタンカリウムの結晶化方法
CA2482857A1 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
WO2004039352A2 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of losartan potassium
EP1608641A1 (en) * 2003-04-03 2005-12-28 IPCA Laboratories Limited A process for the synthesis of losartan potassium
US6916935B2 (en) * 2003-05-06 2005-07-12 Ipca Laboratories Losartan potassium synthesis
US7345071B2 (en) 2003-05-07 2008-03-18 Ipca Laboratories Limited Process for the synthesis of Losartan potassium
EP1709034A2 (en) * 2004-01-06 2006-10-11 IPCA Laboratories Limited An improved process for the synthesis of losartan potassium
WO2006050922A1 (en) 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
ITTO20060560A1 (it) * 2006-07-27 2008-01-28 S I M S S R L Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
JP5399902B2 (ja) * 2006-08-22 2014-01-29 ランバクシー ラボラトリーズ リミテッド マトリックスメタロプロテイナーゼ阻害剤
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4221583A1 (de) * 1991-11-12 1993-05-13 Bayer Ag Substituierte biphenylpyridone
KR100212257B1 (ko) 1991-11-18 1999-08-02 미리암 디. 메코나헤이 Aii 수용체 길항물질을 합성하기 위한 테트라졸릴페닐보론산 중간체의 제조 방법
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
EP0736021A4 (en) 1993-12-23 1997-04-02 Merck & Co Inc LOSARTANE POLYMORPHS AND PROCESS FOR THE PREPARATION OF FORM II OF LOSARTANE
JP3883205B2 (ja) * 1994-03-29 2007-02-21 メルク エンド カンパニー インコーポレーテッド アンギオテンシン▲ii▼レセプタ遮断イミダゾールによるアテローム性動脈硬化症の治療
ES2105939B1 (es) * 1994-08-02 1998-07-01 Uriach & Cia Sa J Nuevos pirazoles con actividad antagonista de la angiotensina ii.

Also Published As

Publication number Publication date
SK286740B6 (sk) 2009-04-06
CZ301029B6 (cs) 2009-10-14
HU222773B1 (hu) 2003-10-28
TR200401058T4 (tr) 2004-06-21
ATE259366T1 (de) 2004-02-15
PL356929A1 (en) 2004-07-12
AU2001254998A1 (en) 2001-11-07
WO2001081336A8 (en) 2002-08-29
EP1274702B1 (en) 2004-02-11
BG107031A (en) 2003-08-29
SK12892002A3 (sk) 2002-12-03
ES2215130T3 (es) 2004-10-01
DE60102008D1 (de) 2004-03-18
US6710183B2 (en) 2004-03-23
HU0001618D0 (en) 2000-06-28
EP1274702A1 (en) 2003-01-15
PL198664B1 (pl) 2008-07-31
JP2003531203A (ja) 2003-10-21
EA004633B1 (ru) 2004-06-24
EE200200460A (et) 2003-12-15
WO2001081336A1 (en) 2001-11-01
EE05064B1 (et) 2008-08-15
HUP0001618A2 (hu) 2002-11-28
BG65699B1 (bg) 2009-07-31
US20030078435A1 (en) 2003-04-24
DE60102008T2 (de) 2004-12-09
UA72803C2 (en) 2005-04-15

Similar Documents

Publication Publication Date Title
EA200201122A1 (ru) Способ получения производного тетразола
EA201070437A3 (ru) Способ получения 2'-дезокси -5-азацитидина (децитабина)
RU2009133453A (ru) Фторсодержащее пиразолкарбонитрильное производное и способ его получения и фторсодержащее производное пиразолкарбоновой кислоты, полученное с применением фторсодержащего пиразолкарбонитрильного производного и способ его получения
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
BRPI0408160B1 (pt) Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo
NO20075829L (no) Syntese
EA200501321A1 (ru) Способ получения глимепирида и соответствующего промежуточного соединения
AU679140B2 (en) Process for preparing polyazamacrocycles
TW200740763A (en) A method for preparing 5-hydroxy-1-alkyl pyrazole derivatives
NO330965B1 (no) Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt
JP4698974B2 (ja) 3−o−アルキルアスコルビン酸の製造法
JP2885944B2 (ja) 複素環基を有するアミン化合物
EA200501135A1 (ru) Способы получения алкалоидов хиназолина
JPH04273872A (ja) 新規ジケテンイミン誘導体およびその製造方法
RU2454401C1 (ru) Способ получения 4-(1-адамантил)-1,2-диаминобензола
RU2330013C1 (ru) Способ получения адамантилсодержащих производных симметричных 1,4-дикетонов
DE502005006682D1 (de) Methyllithium/Lithiumbromid enthaltendes Synthesemittel und Verfahren zu dessen Herstellung
DE602004015151D1 (de) Verfahren zur kontinuierlichen synthese von monoalkylhydrazinen mit einer funktionalisierten alkylgruppe
Fabre et al. An unexpected synthesis of ketene monothioacetals
RS50448B (sr) Postupak za sintezu heterocikličnih aminoalkil benzamida
XIE et al. Synthesis and biological activities of novel thiocarbohydrazone derivatives
LV14445A (lv) 3-dezoksi-3-(1-(1,2,3-triazolil)metil)allozes atvasinājumi kā glikozidāžu inhibitori
TH128482B (th) กระบวนการแบบใหม่สำหรับการสังเคราะห์ไอวาบราดีนและเกลือที่ได้จากการเติมของสิ่งนั้นด้วยกรดที่สามารถยอมรับได้ทางเภสัชกรรม
JO3022B1 (ar) طريقة لانتاج 2'-دياوكسي-5-ازاسيتيدين (ديسيتابين)
TH78688A (th) กรรมวิธีสำหรับการเตรียมไพราโซล

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU